Why Biogen Stock Was a Winner on Wednesday
Source: Motley Fool
2026-04-29 20:06:53 ET
Prominent biotech Biogen (NASDAQ: BIIB) loomed large on the stock market on Wednesday. It published its latest set of quarterly earnings, and investors greeted the estimates-beating numbers by piling into the stock, despite a notable guidance cut. By the end of the trading day, Biogen's shares had gained 6%.
Biogen's total revenue for the first quarter of 2026 was $2.48 billion, up 2% year over year. This was sufficient to top the consensus prognosticator forecast of $2.25 billion.
Image source: Getty Images.
Biogen Inc.
NASDAQ: BIIB
BIIB Trading
-1.09% G/L:
$190.25 Last:
516,651 Volume:
$194.02 Open:
BIIB Latest News
BIIB Stock Data
$28,113,797,416
145,290,943
N/A
471
N/A
Pharmaceuticals
Healthcare
US
Cambridge
